Tirzapetide dose escalation schedules were slower in the real-world than clinical settings among individuals with obesity without T2D.

The government has instead directed that a school-level SMC Election Committee, headed by the concerned head of the school, will conduct elections to reconstitute a new SMC for their respective ...

Age Illness Level of physical activity Medications Stress The following chart includes general guidelines for blood sugar levels measured in milligrams per deciliter (mg/dL). Age Normal fasting ...

MEGHAN’S podcast is a chart flop — and less popular than a show about sleep. The Duchess of Sussex’s Confessions of a Female Founder — focusing on entrepreneurs — has dropped out of the ...

In October of last year, when the FDA removed Lilly’s tirzepatide from the shortage list, the OFA and Texas-based FarmaKeio Superior Custom Compounding filed a lawsuit, claiming that the ...

The Boston Celtics and Orlando Magic are set to clash in Game 3 of their first-round NBA playoff series at the Kia Center on Friday. Despite facing challenges in the opening two games, the ...

Following the Pahalgam terror attack, which resulted in 28 fatalities, Pakistan's leadership is convening a National Security Committee meeting to formulate a ...

Here's how you can use Napkin AI to create charts and graphs from your data. Sign up to get the BEST of Tom's Guide direct to your inbox. Get instant access to breaking news, the hottest reviews ...

In December, the FDA declared that Eli Lilly's weight loss and diabetes medication tirzepatide, sold under the brand names Mounjaro and Zepbound, was no longer in short supply. The Outsourcing ...

With New York adding Dart to the roster, let's take a look at the Giants' new quarterback depth chart. The Giants trading up to get a dynamic playmaker like Dart may mean Wilson could have some ...

Credit: Getty Images With the FDA approval of Zepbound (tirzepatide) for obstructive sleep apnea, GLP-1 receptor agonists harbor potential beyond weight and diabetes management. In recent years, ...

On Thursday, the pharma sued four telehealth providers which were allegedly selling compounded tirzepatide, engaging in deceptive marketing tactics to make it seem like their products were approved or ...